Boundless Bio Inc [BOLD] stock prices are up 8.40% to $1.42 at the moment. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The BOLD shares have gain 19.33% over the last week, with a monthly amount drifted -9.55%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Boundless Bio Inc [NASDAQ: BOLD] stock has seen the most recent analyst activity on December 13, 2024, when Guggenheim downgraded its rating to a Neutral. Previously, Piper Sandler started tracking the stock with Overweight rating on April 22, 2024, and set its price target to $20. On April 22, 2024, Leerink Partners initiated with a Outperform rating and assigned a price target of $25 on the stock. Guggenheim started tracking the stock assigning a Buy rating and suggested a price target of $24 on April 22, 2024.
The stock price of Boundless Bio Inc [BOLD] has been fluctuating between $1.06 and $12.65 over the past year. Boundless Bio Inc [NASDAQ: BOLD] shares were valued at $1.42 at the most recent close of the market.
Analyzing the BOLD fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.32, Equity is -0.43 and Total Capital is -0.37. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.32.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.3133 points at the first support level, and at 1.2067 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.4833, and for the 2nd resistance point, it is at 1.5467.
Ratios To Look Out For
It’s worth pointing out that Boundless Bio Inc [NASDAQ:BOLD]’s Current Ratio is 18.98. In addition, the Quick Ratio stands at 18.98 and the Cash Ratio stands at 3.27.
